ROLE OF COMBINATION DRUG THERAPY FOR MANAGEMENT OF HYPERTENSION WITH INCREASING AGE

PARTAP BIR SINGH; SUKHRAJ SINGH; GURPREET KAUR GILL

doi:10.22159/ajpcr.2021.v14i10.42431

Authors

PARTAP BIR SINGH Department of Medical Laboratory Technology, Khalsa College of Pharmacy and Technology, Amritsar, Punjab, India.
SUKHRAJ SINGH Department of Medical Laboratory Technology, Khalsa College of Pharmacy and Technology, Amritsar, Punjab, India.
GURPREET KAUR GILL Department of Medical Laboratory Technology, Khalsa College of Pharmacy and Technology, Amritsar, Punjab, India.

DOI:

https://doi.org/10.22159/ajpcr.2021.v14i10.42431

Keywords:

Hypertension, Low-density lipoprotein, Triglycerides, Cholesterol and blood pressure

Abstract

Objective: In South Asia, hypertension is the third highest factor contributing in public health burden of disease and major risk factor for coronary artery disease especially in women and old age people. The study was aimed to determine the role of gender and age (20–80 years) on severity of hypertension to design an effective schedule for management of hypertension.

Methods: The levels of serum cholesterol, triglycerides (TG), high-density lipoprotein (HDL), low-density lipoproteins (LDL), and blood pressure (BP) of 240 hypertensive patients were monitored. Cholesterol, TG, and HDL levels were detected using ERBA Reagent kit of Transasia Bio-medicals LTD by CHOD-PAP, glycerol phosphate oxidase trinder End point, and polyvinyl sulfonic and polyethyleneglycol-methyl ether based methods, respectively.

Results: The BP and levels of serum cholesterol, TG and LDL were increased in both the genders after 40 years of age. However, the rise in levels of these parameters was more in females in comparison to males. A hypertension management schedule involving (BP)/Cholesterol lowering drugs and lifestyle changes for period of 60 days showed that combination drug therapy was more effective than monotherapies of same drugs used at higher dosages.

Conclusion: Hypertensive patients strictly followed the prescribed healthy food and exercise schedule showed improvement in their BP and lipid profile even with limited drug intervention.

Downloads

Download data is not yet available.

References

Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747-57.

Mackay J, Mensah GA. The Atlas of Heart Disease and Stroke. Geneva:World Health Organization; 2004.

Hypertension Study Group. Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: A multicentre study. Bull World Health Organ 2001;79:490.

Littlejohn TW, Majul CR, Olvera R, Seeber M, Kobe M, Guthrie R, et al. Results of treatment with telmisartan-amlodipine in hypertensive patients. J Clin Hypertens 2009;11:207-13.

Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomized trial. Lancet 1998;351:1755-62.

Eapen DJ, Kalra, GL, Rifai L, Eapen CA, Merchant N, Khan BV. Raising HDL cholesterol in women. Int J Womens Health Wellness 2009;1:181.

Sun LP, Seemann J, Goldstein JL, Brown MS. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins. Proc Natl Acad Sci 2007;104:6519-26.

Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2224-60.

Poehlman ET, Toth MJ, Ades PA, Rosen CJ. Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: A longitudinal study. Eur J Clin Invest 1997;4:322-6.

Moser M, Franklin SS. Hypertension management: Results of a new national survey for the hypertension education foundation: Harris interactive. J Clin Hypertens 2007;9:316-23.

Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endo Crinol Metab 2003;88:2404-11.

Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993;14:20-39.

Sowers JR. Hypertension in the elderly. Am J Med 1987;82:1-8.

Elahi D, Muller DC, Egan J.M, Andres R, Veldhuis J, Meneilly GS. Glucose Tolerance, Glucose Utilization and Insulin Secretion in Ageing, Novartis Foundation Symposia. Chichester, New York: John Wiley; 2002. p. 222-46.

Parini P, Angelin B, Rudling M, Cholesterol and lipoprotein metabolism in aging: Reversal of hypercholesterolemia by growth hormone treatment in old rats. Arterioscler Thromb Vasc Biol 1999;19:832-9.